Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21930,193,1.47 [1.01-2.13],0.0439998189604473
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23144,247,1.26 [0.89-1.78],0.1864485165340193
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22865,1756,1.19 [1.04-1.35],0.0121277750628437
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,23150,555,1.29 [1.03-1.62],0.0257696701527591
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22388,4236,1.26 [1.15-1.37],1.4286689320524332e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22328,4318,1.19 [1.09-1.29],5.829622933052291e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22861,1430,1.16 [1.01-1.34],0.0417823161310451
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23055,128,1.27 [0.79-2.05],0.3197360976091766
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20308,1299,1.29 [1.11-1.51],0.0010805002242324
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19596,1586,1.35 [1.18-1.55],1.8596612356002625e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19098,345,1.35 [1.00-1.82],0.0480076399007281
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15055,2754,1.30 [1.17-1.45],8.564302832902498e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19030,494,1.56 [1.22-1.98],0.0003203308914489
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23127,1696,1.16 [1.02-1.33],0.025800638012551
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Mycoses,23244,649,1.30 [1.05-1.60],0.0148423226698786
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22347,1238,1.20 [1.02-1.40],0.0250538733278897
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23170,1433,1.30 [1.13-1.50],0.0002903286062731
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21678,247,1.26 [0.90-1.78],0.1830794624819156
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23304,66,1.97 [1.23-3.16],0.0049207351768104
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22989,1252,1.23 [1.06-1.44],0.0069622785423259
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23005,78,1.31 [0.71-2.43],0.3839059356307607
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23239,141,1.57 [1.04-2.37],0.0332251814362914
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23216,118,1.68 [1.10-2.58],0.0164737761473482
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21616,507,1.10 [0.86-1.41],0.4397170720545996
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21420,311,1.39 [1.02-1.90],0.0370871712979481
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21568,137,1.56 [1.04-2.34],0.0334179817325147
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23289,53,2.01 [1.15-3.53],0.0150283780545043
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23235,172,1.27 [0.84-1.91],0.2578060551017211
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Viral warts,23118,55,1.91 [1.12-3.26],0.0171598380926588
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23142,79,1.63 [0.96-2.76],0.0678902614842656
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign lipomatous neoplasm,23010,267,0.87 [0.62-1.22],0.4312111630833549
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23222,39,0.83 [0.34-2.04],0.6792942541410882
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23202,43,1.83 [0.90-3.73],0.0965486445173249
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11100,85,0.60 [0.33-1.08],0.0887430349638926
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22832,1690,1.20 [1.05-1.37],0.0068402359095015
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm of meninges,23288,65,1.21 [0.61-2.41],0.5803776386572785
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23207,80,0.52 [0.28-0.97],0.040343689570181
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23277,121,0.68 [0.41-1.14],0.1471835750189155
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm of ovary,12135,80,1.51 [0.88-2.58],0.1333248165825419
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23264,445,1.05 [0.81-1.36],0.7336034674765262
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm: Caecum,23269,387,1.17 [0.88-1.54],0.2740181112590252
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23155,88,0.55 [0.31-0.99],0.0443803467698192
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,23260,257,1.31 [0.94-1.82],0.1133242487559322
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm: Rectum,23219,409,0.99 [0.75-1.30],0.9322635160139984
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23145,682,1.20 [0.98-1.48],0.0783747533537049
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23245,547,1.13 [0.89-1.42],0.3132971200211772
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Carcinoma in situ of breast,9129,48,0.68 [0.29-1.60],0.3765877658457256
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9173,67,1.02 [0.50-2.08],0.9514927685277824
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16637,73,0.87 [0.46-1.67],0.680132374805841
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16665,101,0.81 [0.47-1.41],0.4556272642101118
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23247,126,0.85 [0.51-1.40],0.5165336272573546
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Haemangioma, any site",23248,123,0.87 [0.52-1.45],0.5984010236275091
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Leiomyoma of uterus,11861,169,1.40 [0.94-2.08],0.0960924606443998
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Lung cancer and mesothelioma,14739,483,1.59 [1.24-2.06],0.000336474999179
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Lymphoid leukaemia,16638,74,0.76 [0.40-1.46],0.4167580304470688
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16787,223,1.07 [0.74-1.54],0.7332551279725705
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16887,323,1.47 [1.10-1.95],0.0086211266031197
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9251,103,0.87 [0.49-1.55],0.6366710034477723
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16674,110,1.83 [1.21-2.78],0.0045206650908162
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16710,146,1.18 [0.75-1.84],0.4782130349619709
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16688,124,1.19 [0.73-1.93],0.4883178665903446
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9234,86,1.13 [0.62-2.06],0.6817179564635825
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16691,127,0.75 [0.46-1.23],0.2576783563116044
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8391,975,0.98 [0.83-1.17],0.8400032570490774
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16700,136,0.74 [0.46-1.18],0.2024596300248965
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16655,91,1.15 [0.65-2.03],0.6217352547792794
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16707,143,1.00 [0.63-1.60],0.9882237488928276
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Melanocytic naevi,23157,186,0.93 [0.61-1.40],0.7213321206155261
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Melanocytic naevi of trunk,23276,79,0.98 [0.53-1.82],0.9494726278553814
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Melanoma in situ,16617,110,0.61 [0.36-1.04],0.0698706005327459
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16688,124,0.90 [0.55-1.48],0.6730673176242647
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16768,204,0.82 [0.55-1.21],0.3162948214097229
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16892,328,1.43 [1.07-1.90],0.014442690512565
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16695,131,0.69 [0.43-1.13],0.1429449930372317
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,Other benign neoplasms of skin,23131,165,1.05 [0.68-1.62],0.8174529498497913
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18066,1502,0.93 [0.80-1.07],0.3059869588260834
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18148,1584,0.95 [0.82-1.09],0.4479131067199305
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22995,398,1.36 [1.04-1.78],0.0255620529398237
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20974,165,1.88 [1.36-2.60],0.000138183820512
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22667,70,1.15 [0.60-2.21],0.6833173063346756
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22530,3509,0.92 [0.84-1.01],0.0831857488582273
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21572,74,1.64 [0.94-2.85],0.0816026740413086
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22830,64,0.74 [0.37-1.48],0.3927821364677977
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22787,1978,0.92 [0.81-1.05],0.221337447117348
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22786,1977,0.92 [0.81-1.05],0.2169956457968408
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20924,115,1.69 [1.07-2.65],0.0230285747486029
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22935,1437,0.75 [0.64-0.87],0.0001066916070043
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22877,111,0.75 [0.44-1.29],0.3008753919779231
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22672,75,1.48 [0.81-2.72],0.2046818345938875
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22673,76,1.16 [0.62-2.17],0.6507209854429034
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23123,357,1.32 [1.00-1.76],0.0525869530227388
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23172,40,2.35 [1.42-3.87],0.0008675969947061
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23058,292,1.53 [1.13-2.06],0.005216347728169
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21634,136,1.07 [0.67-1.73],0.7726678817680133
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15588,421,2.08 [1.61-2.70],3.160295638300188e-08
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21785,102,1.70 [0.94-3.06],0.0784438970972066
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21796,113,2.26 [1.59-3.22],6.1282716924872215e-06
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15239,72,0.92 [0.47-1.80],0.8140239988380064
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21646,65,1.12 [0.57-2.21],0.7464885137430822
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20850,319,1.45 [1.09-1.92],0.0104420066620222
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22500,955,1.07 [0.89-1.27],0.4773015626090997
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22032,487,1.11 [0.87-1.42],0.3889259821504238
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21765,220,0.80 [0.55-1.17],0.2532435638067182
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23016,1435,1.06 [0.92-1.23],0.4311800352612471
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19611,1391,1.07 [0.92-1.24],0.4075419104714246
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15261,94,1.63 [0.93-2.86],0.0908702709157312
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20991,97,1.16 [0.66-2.03],0.6044099713777389
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15533,366,1.34 [1.00-1.79],0.0469731429720432
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15223,56,3.10 [1.81-5.33],4.0109218224588815e-05
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19797,4630,1.24 [1.14-1.35],3.46543235438256e-07
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15432,265,1.59 [1.12-2.24],0.0086887434247503
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15879,712,1.51 [1.23-1.85],6.659985129964053e-05
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23245,374,1.30 [0.98-1.72],0.0647698104091367
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23033,162,1.46 [0.98-2.19],0.0655795973230909
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15322,155,1.44 [0.93-2.25],0.1050157896635696
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15249,82,1.29 [0.69-2.39],0.4273736095033713
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22659,1765,0.96 [0.83-1.09],0.5142503071376996
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15558,391,1.23 [0.93-1.63],0.1444432981265367
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15595,428,1.80 [1.39-2.34],1.0334644569783535e-05
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16041,874,1.30 [1.07-1.57],0.0070945423927094
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15345,178,1.18 [0.78-1.80],0.4276895500414076
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23023,152,1.35 [0.88-2.08],0.1690818584672951
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,16068,901,1.15 [0.95-1.38],0.1435580795177358
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15826,659,1.11 [0.89-1.39],0.3575403130736607
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20611,80,0.98 [0.52-1.82],0.9367137448409408
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21642,6475,1.26 [1.17-1.34],3.8948461310017376e-11
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20951,57,1.08 [0.51-2.26],0.8453917303410827
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20944,50,1.89 [1.09-3.29],0.0230270469541758
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23116,1928,0.92 [0.81-1.04],0.1850166057728327
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23114,1926,0.91 [0.81-1.04],0.1601673341671685
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20960,66,0.88 [0.43-1.76],0.7109681721066379
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22947,1144,0.87 [0.74-1.03],0.112749393760262
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17421,2254,1.28 [1.14-1.44],2.3401671477026507e-05
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23288,318,2.07 [1.66-2.59],1.428099885949536e-10
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21678,133,1.20 [0.76-1.91],0.4343001499638631
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21921,118,0.97 [0.58-1.63],0.9039565786795905
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21968,165,1.09 [0.70-1.69],0.707521058477165
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15365,198,1.14 [0.75-1.73],0.5394594597803022
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20485,185,2.15 [1.64-2.84],4.369776691105109e-08
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2491,102,1.72 [1.03-2.88],0.0373821046379529
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2659,312,1.55 [1.14-2.09],0.0046750539548166
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20388,88,2.44 [1.61-3.69],2.348568004042728e-05
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2463,77,3.10 [1.69-5.68],0.0002481146980067
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22448,2148,1.96 [1.78-2.15],8.943956885286186e-44
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22176,631,1.04 [0.83-1.29],0.7406778381783512
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20984,453,1.33 [1.04-1.70],0.0231454427004898
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16293,1126,1.62 [1.40-1.88],2.0646600608304422e-10
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23169,306,1.24 [0.91-1.68],0.1770809947830839
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21786,270,1.27 [0.92-1.76],0.1486646706613404
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Angina pectoris,20126,1585,1.11 [0.97-1.27],0.1371113014414643
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21890,374,1.13 [0.85-1.49],0.396674281879436
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21606,90,2.26 [1.56-3.28],1.5353687676572987e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21808,292,1.64 [1.23-2.18],0.0007446777652062
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11779,2860,0.91 [0.82-1.01],0.0844533572800866
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,AV-block,17694,684,0.97 [0.78-1.21],0.8008111475284256
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23221,584,0.91 [0.72-1.14],0.3926318034528694
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,9189,270,1.23 [0.87-1.75],0.2396714690389238
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17214,204,0.70 [0.47-1.04],0.0796378476039191
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17121,111,0.74 [0.43-1.26],0.2630096661679786
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23299,82,1.89 [1.16-3.08],0.0107729629592536
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Conduction disorders,18586,1576,0.90 [0.78-1.04],0.1568855128771973
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21291,2775,1.06 [0.95-1.17],0.2900418577161099
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18691,8963,1.17 [1.11-1.24],1.1384937507516521e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21716,337,1.23 [0.92-1.65],0.1670103464885886
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Endocarditis,17112,102,0.49 [0.28-0.85],0.0118981091407527
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23006,1679,0.95 [0.83-1.09],0.4718622363413158
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Hypertension,19937,7978,1.20 [1.13-1.28],6.1700169300799924e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19956,7997,1.20 [1.13-1.28],6.087932317419271e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23130,99,2.92 [2.27-3.75],7.713538556069555e-17
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12227,268,0.56 [0.40-0.78],0.0007207134970312
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12172,213,1.95 [1.37-2.78],0.000200733144061
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Hypotension,23119,1657,1.19 [1.05-1.36],0.0091278933430955
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21999,149,0.67 [0.42-1.06],0.0858141659144105
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21465,2924,1.09 [0.98-1.20],0.1094351065674074
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22781,803,1.40 [1.16-1.68],0.0003741402548983
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17541,531,1.13 [0.88-1.44],0.3381443645260029
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22602,1071,1.40 [1.19-1.64],3.918265698674849e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19464,923,1.36 [1.14-1.61],0.0006375098328143
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23174,189,1.36 [0.92-2.00],0.1188111716046669
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23258,412,1.37 [1.06-1.78],0.0173947966451653
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,21448,69,2.97 [2.23-3.94],5.3144271163943095e-14
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other aneurysm,21621,105,0.98 [0.57-1.67],0.93433975765985
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,17615,605,0.78 [0.62-0.99],0.0379081778541711
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21655,139,2.04 [1.42-2.92],0.0001001874986577
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21849,333,1.56 [1.19-2.04],0.0014063687184312
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17237,227,0.73 [0.50-1.07],0.1054075043979283
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,21497,118,1.44 [0.89-2.33],0.1411039192285193
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21426,47,1.65 [0.82-3.31],0.1593721234888372
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21229,92,0.72 [0.40-1.28],0.2581223711778113
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21561,182,1.09 [0.72-1.65],0.6745881145167669
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18483,1473,0.73 [0.63-0.84],2.134522966021604e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21525,63,2.99 [2.26-3.96],1.7038793029266953e-14
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22257,741,1.20 [0.98-1.46],0.0731801509940852
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22529,536,0.68 [0.54-0.86],0.00156303921901
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22122,985,1.21 [1.01-1.43],0.0344846070289744
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9337,418,0.72 [0.55-0.96],0.0243557590507665
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22081,602,1.43 [1.16-1.77],0.0010153204913342
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21807,428,1.19 [0.91-1.55],0.2036705468368777
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22596,603,0.97 [0.78-1.22],0.8179243082835694
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23203,977,0.77 [0.64-0.92],0.0041593523369806
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17533,523,0.89 [0.70-1.15],0.3773908350138428
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22522,529,0.66 [0.52-0.84],0.0006171171230543
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21405,268,1.56 [1.14-2.12],0.0049364754583971
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22765,915,1.26 [1.06-1.51],0.0094879935832005
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22750,956,1.25 [1.05-1.49],0.0122170739695142
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21967,64,0.85 [0.42-1.74],0.6555948562488075
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21622,106,0.84 [0.49-1.44],0.5213961577894581
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22305,327,1.08 [0.79-1.46],0.6419175326041711
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21868,337,1.21 [0.90-1.63],0.2031133707119549
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Varicose veins,21901,522,1.09 [0.85-1.39],0.4891388806361383
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21535,121,1.00 [0.60-1.66],0.9946931976112872
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23023,954,1.07 [0.90-1.28],0.446740719532657
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23220,333,1.91 [1.49-2.45],3.1740414264758444e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19910,1393,0.97 [0.84-1.13],0.7294871717841751
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Any mental disorder,22765,4248,1.11 [1.02-1.20],0.0200392088448564
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23191,392,1.95 [1.56-2.44],4.941176584023634e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19980,1463,1.05 [0.91-1.22],0.5031962810921593
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18602,85,0.97 [0.53-1.79],0.9327729541992292
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Smoking dependency,22788,1188,1.23 [1.05-1.45],0.0096887152486647
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19977,1460,1.30 [1.13-1.49],0.0002824204664998
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Vascular dementia,22394,228,1.50 [1.09-2.07],0.0140443781439743
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Alzheimer disease,23300,597,1.17 [0.94-1.45],0.1717583121288473
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14274,112,1.49 [0.87-2.55],0.1511009826453833
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Bell's palsy,21436,85,1.91 [1.22-2.98],0.0043561025597812
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21849,498,1.07 [0.83-1.37],0.5906628403519925
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Cerebral cysts,22847,251,1.13 [0.80-1.61],0.4846991254685777
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23227,412,1.41 [1.09-1.83],0.0080787292482176
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22438,77,1.46 [0.82-2.62],0.1974886714409568
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23282,70,1.06 [0.55-2.04],0.857773011986659
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22682,86,1.14 [0.63-2.07],0.6638212935787289
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Epilepsy,21777,309,1.39 [1.02-1.90],0.0358059396961404
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22830,1362,1.05 [0.91-1.23],0.4948955913937103
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23248,923,1.05 [0.88-1.26],0.5868931289007886
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22633,3471,1.12 [1.02-1.23],0.0216189231930964
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,22913,54,2.16 [1.37-3.42],0.0009397330014726
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Hemiplegia,23153,338,1.44 [1.09-1.91],0.0106125511310097
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Hydrocephalus,22669,73,1.00 [0.51-1.93],0.9887943622124178
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23287,71,1.62 [0.92-2.86],0.0965408803977024
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21419,68,0.74 [0.37-1.50],0.4055540798314823
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21425,74,1.54 [0.85-2.79],0.1505067966936475
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Memory loss,22143,143,0.87 [0.54-1.38],0.5475701222789862
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Migraine,21747,279,1.26 [0.91-1.76],0.1698489644502885
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23252,256,1.31 [0.93-1.85],0.1215099986351363
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Motor neuron disease,14364,178,1.13 [0.73-1.73],0.5886032582150481
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23169,60,1.09 [0.53-2.23],0.8212042842330962
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22586,1235,1.15 [0.98-1.35],0.0774756377108432
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Neurological diseases,21800,4386,1.10 [1.01-1.19],0.0334388685429494
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22689,328,1.27 [0.95-1.70],0.1107426648011855
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21778,427,0.98 [0.75-1.28],0.8749967622660765
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23221,356,1.64 [1.27-2.12],0.000178163152071
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17435,988,1.31 [1.09-1.57],0.0033853040958762
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22685,89,1.07 [0.59-1.93],0.8252928664218233
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22759,163,1.68 [1.11-2.55],0.0143035912704038
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22562,237,1.37 [0.98-1.92],0.0646555652542518
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21447,96,1.91 [1.25-2.91],0.0025707159292696
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other headache syndromes,21521,53,1.23 [0.57-2.66],0.6042215439161869
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other neurological diseases,23186,590,1.25 [0.99-1.57],0.0556540262250244
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other sleep disorders,21989,521,0.92 [0.72-1.17],0.4972590077551958
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Parkinson's disease,23269,681,0.99 [0.80-1.22],0.9088344091931964
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22642,46,1.62 [0.76-3.47],0.2152012491196642
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,23301,107,1.19 [0.70-2.01],0.5238910337336392
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Sleep apnoea,23066,442,0.86 [0.66-1.11],0.2544667485942848
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22926,61,1.65 [0.92-2.98],0.0955937657101807
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23289,207,1.12 [0.76-1.64],0.5651232986382793
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21420,69,0.79 [0.40-1.57],0.5050255910124049
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23300,603,1.18 [0.95-1.47],0.1361627652910449
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22331,222,1.46 [1.05-2.04],0.0247160610331019
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22653,156,1.59 [1.10-2.32],0.0144063218716628
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22837,565,0.87 [0.68-1.10],0.2480969351483508
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23042,270,2.37 [1.92-2.93],1.5937221819206037e-15
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22053,70,0.70 [0.36-1.37],0.2992156540922611
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22021,38,0.70 [0.28-1.75],0.4481569152957462
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23177,73,2.03 [1.35-3.05],0.0006715856375418
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22978,227,0.62 [0.42-0.90],0.012921163405431
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2467,78,3.24 [1.78-5.89],0.0001198205908336
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3048,117,1.90 [1.18-3.06],0.0086014485966515
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22601,104,1.12 [0.65-1.93],0.6858438463701648
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22995,1436,1.20 [1.04-1.39],0.0126000679794945
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22881,898,0.90 [0.75-1.09],0.2881321873966793
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22291,308,0.93 [0.67-1.29],0.669707089923409
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23225,953,0.89 [0.74-1.07],0.2304034685863796
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23294,82,1.12 [0.61-2.05],0.7184988664029922
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23151,879,0.89 [0.74-1.08],0.2393579943617382
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23257,506,0.79 [0.61-1.01],0.0639847823065969
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23179,228,1.28 [0.90-1.83],0.1653603552430198
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22084,101,0.78 [0.45-1.35],0.3770120661099396
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22090,107,0.85 [0.50-1.46],0.5550118180171002
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22060,77,0.72 [0.38-1.38],0.3281769482104196
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23162,1028,1.02 [0.85-1.21],0.8555493609564649
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22404,270,0.92 [0.65-1.29],0.6122371552997893
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22345,73,1.02 [0.53-1.96],0.9573409720894308
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22877,126,0.96 [0.58-1.58],0.8740656241395139
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23145,394,0.77 [0.57-1.02],0.0683027704242738
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22493,221,1.09 [0.75-1.58],0.6578771987400989
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23095,144,1.07 [0.67-1.71],0.7766194170295123
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22821,687,1.19 [0.96-1.46],0.1099911869827468
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22658,161,1.01 [0.65-1.57],0.9491091624862306
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20833,3268,1.19 [1.08-1.31],0.0003040466840966
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23100,349,0.77 [0.57-1.04],0.0932405041432777
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23287,191,1.27 [0.86-1.88],0.2305534966245735
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22534,551,0.88 [0.70-1.12],0.3035835311310945
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22844,93,0.75 [0.42-1.34],0.3324386628364541
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23285,73,1.02 [0.53-1.94],0.9622118544040056
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22113,130,1.06 [0.65-1.72],0.8216558506654956
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22159,176,0.80 [0.52-1.22],0.3009185718942355
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21724,165,1.17 [0.77-1.79],0.4622900259698266
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22336,64,0.96 [0.48-1.94],0.9175245630233748
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21632,73,0.92 [0.48-1.78],0.8126101469213067
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22250,116,1.03 [0.61-1.74],0.9196439962238244
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22432,298,0.98 [0.71-1.36],0.9021192903424364
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22147,164,0.94 [0.61-1.46],0.7984881598963733
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21655,96,0.89 [0.50-1.58],0.6908584105071294
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21692,133,1.50 [0.97-2.32],0.0697543119006212
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20322,2757,1.11 [1.00-1.24],0.0458551663669473
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22075,92,0.59 [0.33-1.05],0.0749034355594458
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23003,506,1.23 [0.97-1.57],0.08469729952283
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22575,78,1.05 [0.56-1.95],0.889049743385993
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22708,211,1.22 [0.84-1.77],0.3023478166432466
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23078,114,1.06 [0.63-1.80],0.8181052212997016
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23255,141,1.33 [0.85-2.09],0.2156093153757437
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23161,119,1.44 [0.89-2.32],0.1333702164249977
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23029,65,0.71 [0.35-1.43],0.3360417109112555
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23033,69,0.82 [0.41-1.61],0.5602474018147725
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23193,1258,1.13 [0.97-1.32],0.1097487324713561
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22892,957,1.24 [1.04-1.47],0.0172700913984667
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22086,151,1.16 [0.74-1.82],0.5119765129259308
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22025,90,0.70 [0.39-1.27],0.24238851198104
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,23110,68,1.00 [0.51-1.95],0.988650659915735
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23230,188,1.27 [0.86-1.87],0.2369908451076249
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23104,62,2.06 [1.27-3.36],0.0036012486454934
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,All influenza,20594,158,1.91 [1.38-2.64],9.525235101185042e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20591,155,1.92 [1.39-2.66],8.238172458307573e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14360,104,1.51 [0.86-2.63],0.1509380137777291
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,23192,240,1.01 [0.70-1.45],0.9619345033776016
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15587,1726,0.98 [0.85-1.13],0.8009629388499604
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15960,1704,0.98 [0.85-1.13],0.7663806139776458
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22776,181,1.09 [0.73-1.64],0.6733238874561758
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20541,105,1.05 [0.62-1.79],0.8549483853639199
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Bronchiectasis,19534,523,1.63 [1.27-2.08],0.0001004344539848
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19086,75,1.29 [0.67-2.50],0.4414734841863807
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22159,3148,1.18 [1.07-1.31],0.0009429941545327
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22068,73,0.83 [0.43-1.62],0.5894075964371531
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,22131,136,1.00 [0.62-1.61],0.9893500780028428
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23007,1647,1.27 [1.11-1.45],0.0004578267201504
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,22075,80,0.98 [0.53-1.81],0.9398676995535966
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21128,6145,1.15 [1.07-1.24],8.796919878338547e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22335,340,1.08 [0.80-1.45],0.6183979846662189
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Early onset COPD,21470,110,1.56 [0.93-2.63],0.0943789833064278
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Emphysema,19446,435,1.75 [1.34-2.27],3.699723687141779e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21990,458,1.84 [1.48-2.28],3.386922744402717e-08
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23040,2604,1.21 [1.09-1.34],0.0004757915210371
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22034,502,1.91 [1.58-2.31],1.8069769303469358e-11
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Later onset COPD,22773,1537,1.25 [1.09-1.44],0.0012260331031123
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23285,501,1.14 [0.90-1.45],0.2837325738136254
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Nasal polyp,22092,97,1.01 [0.58-1.75],0.985000856740608
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23014,1314,1.45 [1.26-1.67],2.1817571110191545e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,23006,2706,1.18 [1.07-1.31],0.0016396752556031
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22753,758,1.10 [0.90-1.35],0.3387120395649689
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other pleural conditions,20369,69,0.86 [0.44-1.68],0.6530830311864158
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23178,600,1.87 [1.57-2.24],4.732744338568778e-12
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23170,1729,1.22 [1.07-1.39],0.0024888575148944
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Pleural effusion,21681,1381,1.09 [0.94-1.27],0.234786914213235
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Pleural plaque,20552,252,1.08 [0.77-1.53],0.6473657862385862
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22748,2312,1.21 [1.08-1.35],0.0009492841529467
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23176,392,1.12 [0.85-1.47],0.4279124113156667
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Pneumothorax,20469,169,1.15 [0.75-1.76],0.5139236376928027
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Pollen allergy,23289,204,0.92 [0.62-1.37],0.6830698478606316
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,22672,94,1.67 [1.01-2.75],0.0441889929578773
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14326,70,1.88 [0.99-3.57],0.0553376863430531
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22990,1290,1.45 [1.26-1.67],2.789467624992914e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22237,242,1.05 [0.73-1.50],0.7923547680832661
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Viral pneumonia,20740,304,1.39 [1.03-1.89],0.0321026222001246
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22786,242,1.40 [0.99-1.97],0.0546399692838261
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7428,122,0.90 [0.53-1.52],0.6871319097330828
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14770,59,1.35 [0.67-2.74],0.4059045790499764
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Acute appendicitis,23185,128,0.69 [0.42-1.14],0.1502839505709747
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Acute gastritis,16186,107,0.69 [0.40-1.19],0.1838658020695753
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,21242,200,1.10 [0.74-1.63],0.6324007763694273
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Acute peritonitis,22808,110,1.63 [1.03-2.59],0.0389206644378252
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22314,65,0.84 [0.43-1.65],0.6148874504698812
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,16588,509,0.83 [0.64-1.06],0.1381474233451848
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21189,147,1.43 [0.93-2.19],0.1050406616334057
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22879,147,1.44 [0.94-2.21],0.0958065422083171
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Cholecystitis,21266,224,1.18 [0.82-1.69],0.3844861572903757
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Cholelithiasis,22103,1061,1.22 [1.04-1.45],0.0176842055933683
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Chronic gastritis,16429,350,0.78 [0.57-1.06],0.1073343341152891
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21097,55,0.86 [0.41-1.82],0.6973756082594522
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23162,131,2.68 [2.09-3.45],1.6697799596098012e-14
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Coeliac disease,21554,127,0.48 [0.29-0.79],0.0040295915267192
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Collagenous colitis,21551,104,1.20 [0.69-2.08],0.5230116562803181
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23182,159,1.15 [0.74-1.77],0.5370393097301144
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Constipation,23017,2137,1.09 [0.97-1.23],0.1386202207819671
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Crohn disease,21537,90,1.94 [1.16-3.26],0.0119175524494002
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22950,69,1.86 [1.13-3.07],0.0144066668601414
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21529,82,2.06 [1.22-3.49],0.0070600020810457
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Dental caries,22678,188,1.02 [0.68-1.53],0.9360006285512588
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20120,2572,1.00 [0.90-1.12],0.95594615468919
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of appendix,23214,157,0.76 [0.48-1.19],0.2242753193498725
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of liver,23179,930,1.69 [1.45-1.98],4.6779635483858034e-11
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20709,4630,1.03 [0.95-1.12],0.5140066915620538
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22964,474,0.80 [0.62-1.03],0.086378753014842
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23208,510,1.14 [0.89-1.46],0.2869723707600916
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22581,91,0.84 [0.46-1.51],0.5512833476148318
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22458,59,0.78 [0.37-1.62],0.5021673968134147
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22959,1532,0.94 [0.82-1.09],0.4198781554166096
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of tongue,22474,96,1.00 [0.56-1.77],0.9983324065653454
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22578,1536,1.20 [1.04-1.38],0.0100950200916871
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18521,3810,1.01 [0.92-1.11],0.787651010478378
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,16329,250,1.29 [0.91-1.83],0.1539546924221232
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23206,203,1.42 [0.99-2.04],0.0603269845175856
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23262,28,1.85 [0.82-4.14],0.1364166325467136
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22402,153,2.56 [1.99-3.29],2.657522470953312e-13
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14820,109,1.30 [0.77-2.20],0.3319444508109827
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,16646,567,1.07 [0.85-1.36],0.5520930973959
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Gastric ulcer,16509,430,1.22 [0.93-1.60],0.1481995229645127
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18774,2695,0.99 [0.89-1.11],0.8566617766174666
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16735,656,1.21 [0.97-1.50],0.0882171725963188
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16820,8269,1.04 [0.98-1.11],0.2070762126459536
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,GI-bleeding,22701,1274,0.99 [0.85-1.16],0.8845491562439807
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22535,45,0.71 [0.46-1.11],0.1312933306571868
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15707,1189,1.01 [0.85-1.19],0.9233706151273132
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22319,70,2.50 [1.69-3.68],3.789190733760888e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Hernia,21221,3673,0.92 [0.84-1.01],0.0954963790301439
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Impacted teeth,23266,26,1.79 [0.76-4.22],0.1824329445547508
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Impaction of intestines,14790,79,1.37 [0.73-2.56],0.3222878968658551
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Inguinal hernia,18660,1112,0.70 [0.60-0.83],2.537247486838189e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17673,125,0.56 [0.35-0.92],0.0208520025910701
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14826,115,0.69 [0.41-1.18],0.1785371059060064
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21573,146,0.60 [0.37-0.96],0.0344369890175962
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15223,512,1.14 [0.89-1.46],0.2966523463117044
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23268,344,1.97 [1.55-2.50],2.0643939380014708e-08
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22232,785,1.25 [1.03-1.52],0.0246975136934439
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22540,1093,1.30 [1.10-1.53],0.0019971357498229
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16301,222,1.30 [0.90-1.88],0.1682709379621724
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Oesophagitis,16783,704,1.13 [0.92-1.40],0.248361267212838
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23245,130,1.45 [0.92-2.29],0.1088321936009035
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17633,85,0.77 [0.42-1.40],0.3843499690429818
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16093,1382,0.89 [0.77-1.04],0.1516824525634121
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21406,364,1.10 [0.82-1.47],0.5244772900644525
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21189,147,1.25 [0.80-1.95],0.3225556817357567
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,16666,1955,1.06 [0.94-1.21],0.348403508574862
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,20965,6254,1.03 [0.96-1.11],0.3538072118892317
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22431,206,1.39 [0.96-2.00],0.0802036162624774
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of liver,23020,771,1.57 [1.31-1.88],1.044858202829715e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16855,776,0.88 [0.72-1.08],0.2214014466234012
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21259,217,0.91 [0.62-1.33],0.6089051082469794
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23131,433,1.03 [0.79-1.35],0.8096221846213321
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17179,1100,1.06 [0.89-1.25],0.5371496080766667
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22718,1291,0.99 [0.84-1.15],0.8593759904277292
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22669,179,0.78 [0.51-1.18],0.2335667585332502
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16894,2183,1.07 [0.95-1.21],0.2581652478190838
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18269,2190,1.10 [0.98-1.25],0.1056129300332954
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22366,117,2.70 [2.11-3.47],4.449968267857373e-15
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22409,962,1.29 [1.08-1.54],0.0044342937900334
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15163,452,0.95 [0.73-1.24],0.7281544268253237
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23258,32,1.48 [0.60-3.63],0.390815799285771
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15335,624,1.01 [0.81-1.27],0.9222043623161869
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21581,154,1.00 [0.64-1.56],0.9959042120493884
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23289,54,1.15 [0.55-2.44],0.7075761199996444
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22484,105,1.60 [1.00-2.57],0.0492826456538514
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Toxic colitis,21527,80,1.59 [0.88-2.87],0.1264193543445581
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16423,344,0.85 [0.63-1.16],0.3050465384053807
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,21617,170,0.83 [0.54-1.28],0.4102643698705558
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21582,135,0.76 [0.47-1.24],0.2744868075524882
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Umbilical hernia,17805,257,1.42 [1.03-1.97],0.0334875521195255
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14955,244,1.06 [0.74-1.53],0.7343784004568703
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Ventral hernia,17839,291,0.81 [0.58-1.12],0.2071418997375011
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Volvulus,14805,94,1.28 [0.72-2.28],0.4081999942012574
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23194,427,0.91 [0.69-1.19],0.4875333402728825
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22937,66,1.56 [0.79-3.08],0.1955355995304413
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20725,168,1.03 [0.66-1.59],0.9008134039886576
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22653,834,0.97 [0.80-1.17],0.7366765465864469
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21966,147,1.10 [0.70-1.74],0.6739877824288164
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21190,633,1.33 [1.08-1.64],0.0074943103214942
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22952,316,1.40 [1.04-1.88],0.0266361019720605
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23199,563,1.08 [0.86-1.37],0.5040183788025421
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22684,48,0.45 [0.20-0.99],0.0482953182530299
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21689,3768,1.04 [0.95-1.13],0.4413375169910494
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22863,447,1.01 [0.78-1.32],0.9255747088228544
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22728,312,0.98 [0.71-1.34],0.8752314868661144
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22907,1088,0.99 [0.84-1.17],0.931645969089782
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23282,62,1.39 [0.71-2.71],0.3419408782084429
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20614,57,0.63 [0.29-1.37],0.2470501677673915
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22479,63,1.34 [0.70-2.57],0.3833348714111503
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22939,303,1.37 [1.01-1.86],0.0423617665640063
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21169,612,0.89 [0.71-1.12],0.307455313117352
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20648,91,1.12 [0.63-1.99],0.6992270028071251
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23214,94,1.33 [0.77-2.29],0.3137037812902804
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22061,242,1.04 [0.73-1.48],0.8262999713074988
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23095,224,1.20 [0.83-1.73],0.3364894566770096
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22733,97,0.89 [0.50-1.56],0.6773564162980941
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20637,80,0.48 [0.26-0.91],0.0245282938147572
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22687,2130,0.98 [0.87-1.11],0.8005682019973273
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21215,658,0.89 [0.72-1.11],0.3054973501624778
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20652,95,1.08 [0.61-1.90],0.7936496839707962
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23209,338,1.21 [0.90-1.63],0.2148969850750131
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22713,77,0.67 [0.35-1.27],0.2187131986818246
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23146,275,1.17 [0.84-1.63],0.3652606172644729
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23227,460,0.82 [0.63-1.06],0.1318299553163336
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20682,125,0.83 [0.50-1.37],0.4606993306570958
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20897,340,0.79 [0.58-1.07],0.1329498899258371
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23215,448,0.83 [0.64-1.09],0.1793608003474841
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20895,338,1.24 [0.92-1.66],0.1549558020272356
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23274,154,1.47 [0.98-2.22],0.0639170023338422
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19424,83,1.83 [1.10-3.03],0.0191845226721907
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20536,6491,1.00 [0.93-1.08],0.9455088960647752
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19123,5078,0.97 [0.90-1.05],0.4960729501565789
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19393,52,0.75 [0.34-1.63],0.4617360759815965
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19326,146,2.02 [1.36-3.00],0.000473777902389
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19372,192,1.91 [1.46-2.50],2.5828780796095805e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23036,66,1.72 [0.96-3.07],0.0675658737823941
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19331,151,1.24 [0.78-1.95],0.3603809719785127
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15538,1493,0.90 [0.78-1.04],0.1677665996477648
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23092,249,0.98 [0.69-1.40],0.9105921153767882
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19771,591,0.91 [0.72-1.16],0.4554773387340093
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18855,8100,1.00 [0.94-1.07],0.9552327335860548
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20737,122,1.07 [0.64-1.79],0.7882813768815983
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19523,182,1.18 [0.78-1.78],0.4383870399175339
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19857,516,1.30 [1.02-1.67],0.034376133346456
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22356,3176,1.08 [0.98-1.19],0.1405191831172862
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19651,310,1.05 [0.77-1.44],0.7398758408001709
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19494,153,1.34 [0.85-2.13],0.211016900546506
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19461,120,1.45 [0.89-2.39],0.1385934217971481
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22540,100,1.30 [0.76-2.21],0.339909468443725
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16079,2034,0.90 [0.79-1.02],0.0980831829892164
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14846,801,1.42 [1.18-1.70],0.0001971599994517
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23202,794,1.48 [1.23-1.78],2.847990254015088e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14123,78,0.81 [0.42-1.56],0.5319601859305463
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14349,304,0.81 [0.58-1.13],0.2132182451719149
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19608,267,1.20 [0.85-1.69],0.2947611662875272
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14528,483,0.69 [0.53-0.89],0.0045762651332274
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19262,82,1.22 [0.66-2.27],0.5281315094915794
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19869,689,1.23 [0.99-1.52],0.0565473060001245
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19493,313,0.91 [0.66-1.26],0.5809026663204497
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14498,453,0.70 [0.54-0.92],0.009135693372511
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19413,72,0.61 [0.31-1.19],0.1472290628262346
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19400,59,0.91 [0.43-1.89],0.7907265700464483
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20702,87,1.56 [0.88-2.74],0.1273942644228475
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22867,2252,1.14 [1.01-1.29],0.0315750241970342
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22192,1577,1.10 [0.95-1.27],0.2006651285300885
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23128,540,1.40 [1.11-1.75],0.0039474985963896
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17211,3166,1.04 [0.94-1.15],0.4712288517592385
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14088,43,0.87 [0.36-2.07],0.7443564302935799
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19448,107,0.92 [0.53-1.59],0.7603440081805337
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14117,72,0.85 [0.44-1.64],0.6269171823364936
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14177,132,0.83 [0.50-1.39],0.4861466176487163
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20862,247,1.25 [0.87-1.78],0.2249811229585276
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21133,518,1.30 [1.03-1.64],0.025822932667349
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23277,113,1.13 [0.67-1.90],0.6405711831238331
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21191,2011,1.19 [1.06-1.35],0.0045623576807461
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19419,78,1.21 [0.64-2.28],0.5608498704798963
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14201,156,0.50 [0.31-0.79],0.0030483044249783
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19977,797,1.08 [0.89-1.32],0.4359304809056669
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16246,2201,0.95 [0.84-1.07],0.3833751328923966
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22567,127,1.56 [1.02-2.39],0.0413385423279332
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23289,63,1.52 [0.80-2.89],0.1990488086092523
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19420,79,0.69 [0.37-1.30],0.2547149479069551
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20705,1364,1.06 [0.91-1.23],0.4461720474225992
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19448,107,0.98 [0.57-1.69],0.9464206955356096
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16124,2079,1.04 [0.92-1.18],0.5064431076287389
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20733,118,1.05 [0.62-1.78],0.8477219066434002
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19379,38,1.77 [0.77-4.10],0.1821097150891037
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19378,198,1.06 [0.71-1.59],0.7642622250914984
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20029,688,1.23 [1.00-1.51],0.0522597987199397
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22936,496,1.35 [1.07-1.71],0.0122052541960354
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19844,664,1.30 [1.05-1.61],0.0171959319203133
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23142,533,1.43 [1.14-1.80],0.0018090416902662
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23275,68,1.14 [0.58-2.23],0.7056441197955516
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19510,169,1.00 [0.64-1.55],0.985012641685862
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18118,897,1.16 [0.97-1.40],0.111131100516073
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19990,649,1.05 [0.84-1.32],0.6369036201239884
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19619,278,1.05 [0.75-1.46],0.7825735616637545
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14116,71,1.15 [0.59-2.24],0.6788065119244516
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17184,3139,1.12 [1.02-1.24],0.0241539727182321
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14889,844,0.92 [0.75-1.11],0.3853299107919199
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22817,377,1.32 [1.01-1.74],0.0435730887728928
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23244,80,1.24 [0.68-2.27],0.4805383938158708
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20610,71,1.10 [0.58-2.11],0.7652466976573429
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14109,64,1.60 [0.85-3.02],0.1467847546868087
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19289,109,0.60 [0.35-1.02],0.0604879509844173
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14593,548,1.38 [1.10-1.75],0.0064619830119323
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19680,339,1.05 [0.77-1.42],0.7740286169835009
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19474,294,0.83 [0.59-1.15],0.2595271876846859
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19449,269,1.03 [0.73-1.47],0.856357788647306
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16367,68,1.35 [0.72-2.51],0.3495648919433808
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23280,73,1.28 [0.68-2.41],0.4439792891219153
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19899,558,1.09 [0.86-1.39],0.4657171130452859
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22535,95,1.21 [0.69-2.12],0.5081682263400502
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22002,2661,1.05 [0.94-1.17],0.4145244404236015
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19491,150,0.85 [0.53-1.35],0.4883770520018464
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19903,723,0.97 [0.79-1.20],0.7953058693207006
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21925,278,1.02 [0.73-1.42],0.9248961708985008
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19438,258,0.91 [0.63-1.30],0.5896236746467357
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21200,2020,0.99 [0.87-1.12],0.8285324597353181
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20495,1315,0.98 [0.84-1.15],0.8302234190023194
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19405,64,1.09 [0.54-2.22],0.8123491062756594
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22560,120,1.54 [0.99-2.40],0.0541231175426602
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19504,163,1.41 [0.92-2.17],0.1165838676944105
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19433,92,0.79 [0.43-1.45],0.447935910365109
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14123,78,1.63 [0.90-2.95],0.1092185938287524
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21770,2266,1.38 [1.23-1.54],3.5107133985605344e-08
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9338,25,1.46 [0.56-3.80],0.4351663372584214
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11845,34,1.37 [0.53-3.54],0.5130085104674038
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22973,313,1.04 [0.76-1.42],0.8053330069589143
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22763,103,0.87 [0.51-1.49],0.6176992288127903
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21859,2355,1.49 [1.33-1.66],9.380597534919274e-12
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23062,132,2.14 [1.54-2.96],4.972943670006273e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22987,408,1.20 [0.91-1.57],0.1913011704939743
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Cystitis,19433,301,1.08 [0.78-1.49],0.6428903127841084
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Dialysis,19603,99,2.77 [1.83-4.18],1.362196351153251e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10266,2155,0.93 [0.83-1.04],0.2038698984489108
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11944,133,1.00 [0.60-1.65],0.9903116345530072
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,9352,39,1.18 [0.48-2.90],0.7118241230074602
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9894,581,0.97 [0.76-1.23],0.8058042712303176
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19191,6331,1.09 [1.01-1.17],0.019330420095465
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23029,99,2.81 [2.09-3.76],6.391500018448942e-12
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,8229,118,1.05 [0.64-1.71],0.8566777860348052
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19577,354,0.89 [0.66-1.20],0.4364071446955369
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9949,1838,0.91 [0.80-1.03],0.1437947749225815
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12005,160,1.23 [0.79-1.91],0.3514330814860968
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8239,128,0.86 [0.54-1.39],0.5395628260698413
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19221,89,1.27 [0.71-2.30],0.4224199689060937
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10349,1036,0.99 [0.83-1.18],0.9065748590967696
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8173,62,0.84 [0.42-1.65],0.6058884505683424
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9352,39,1.47 [0.68-3.16],0.3255123716626419
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23286,89,0.97 [0.54-1.74],0.9065389781122204
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23288,86,1.18 [0.66-2.12],0.5715410049462293
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22089,2957,1.11 [1.00-1.23],0.0428618976051019
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20082,950,0.89 [0.75-1.07],0.2254038109786117
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11860,49,0.73 [0.32-1.69],0.4671135241407187
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23214,635,1.30 [1.05-1.60],0.0163852447852321
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8265,154,0.81 [0.52-1.24],0.3277934299323923
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8272,161,1.19 [0.78-1.80],0.4250050064274007
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8262,151,0.74 [0.48-1.15],0.175657797392387
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23260,89,1.06 [0.59-1.91],0.8469228410971648
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21479,2347,1.26 [1.13-1.42],7.057031738357455e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11927,82,0.89 [0.46-1.71],0.7251280961365661
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9381,68,0.81 [0.39-1.65],0.5540205455805783
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9458,145,0.78 [0.48-1.27],0.3184663000477101
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9366,53,1.26 [0.60-2.61],0.5437855950044339
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9414,101,1.04 [0.58-1.86],0.885272930527361
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19637,414,0.90 [0.68-1.19],0.4550852672105181
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22782,203,1.34 [0.92-1.93],0.1230388925085778
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9437,124,1.04 [0.62-1.75],0.8729672549899381
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9338,25,0.40 [0.12-1.29],0.1257422871108293
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9526,213,0.78 [0.52-1.17],0.2302263398171039
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9406,93,1.57 [0.98-2.50],0.059872485945068
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9521,208,0.84 [0.56-1.26],0.3943584257549561
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22978,48,1.56 [0.75-3.24],0.2295588790487129
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8265,154,0.79 [0.52-1.22],0.2873197092940336
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23007,3784,1.36 [1.24-1.48],1.1750134675566292e-11
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19314,91,1.50 [0.85-2.66],0.1637742820357361
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19688,184,1.50 [1.00-2.26],0.0503614058636812
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22698,38,1.70 [0.77-3.75],0.193034109098386
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19399,267,1.13 [0.81-1.59],0.4721581983244229
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23058,398,0.98 [0.75-1.30],0.9124120699457928
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9350,37,0.69 [0.26-1.84],0.4619403486201762
